CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 254 filers reported holding CONMED CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,366,042 | +118.6% | 23,461 | +194.6% | 0.05% | +104.2% |
| Q2 2023 | $1,082,228 | +89.6% | 7,964 | +44.9% | 0.02% | +71.4% |
| Q1 2023 | $570,711 | +12.2% | 5,495 | -4.3% | 0.01% | 0.0% |
| Q4 2022 | $508,705 | +104.3% | 5,739 | +85.0% | 0.01% | +100.0% |
| Q3 2022 | $249,000 | -16.2% | 3,102 | 0.0% | 0.01% | -30.0% |
| Q2 2022 | $297,000 | -37.3% | 3,102 | -2.9% | 0.01% | -33.3% |
| Q1 2022 | $474,000 | +4.6% | 3,194 | -0.2% | 0.02% | 0.0% |
| Q4 2021 | $453,000 | -64.2% | 3,199 | -67.0% | 0.02% | -70.6% |
| Q3 2021 | $1,267,000 | +110.5% | 9,682 | +120.9% | 0.05% | +96.2% |
| Q2 2021 | $602,000 | -27.0% | 4,382 | -30.7% | 0.03% | -29.7% |
| Q1 2021 | $825,000 | -42.6% | 6,321 | -50.8% | 0.04% | -22.9% |
| Q4 2020 | $1,438,000 | +22.5% | 12,837 | -14.0% | 0.05% | +26.3% |
| Q3 2020 | $1,174,000 | -54.9% | 14,928 | -58.7% | 0.04% | -51.3% |
| Q2 2020 | $2,605,000 | -4.5% | 36,179 | -24.0% | 0.08% | +2.6% |
| Q1 2020 | $2,728,000 | -20.5% | 47,631 | +55.2% | 0.08% | +20.6% |
| Q4 2019 | $3,432,000 | +260.1% | 30,687 | +167.8% | 0.06% | +350.0% |
| Q1 2019 | $953,000 | -21.1% | 11,460 | -39.1% | 0.01% | -26.3% |
| Q4 2018 | $1,208,000 | -85.4% | 18,816 | -82.0% | 0.02% | -83.3% |
| Q3 2018 | $8,265,000 | +58.3% | 104,331 | +46.3% | 0.11% | +52.0% |
| Q2 2018 | $5,220,000 | +161.3% | 71,309 | +126.1% | 0.08% | +167.9% |
| Q1 2018 | $1,998,000 | -18.8% | 31,542 | -34.7% | 0.03% | -22.2% |
| Q4 2017 | $2,461,000 | -39.4% | 48,285 | -37.7% | 0.04% | -40.0% |
| Q3 2017 | $4,063,000 | +10.8% | 77,442 | +7.6% | 0.06% | +17.6% |
| Q2 2017 | $3,666,000 | +102.9% | 71,967 | +76.9% | 0.05% | +121.7% |
| Q1 2017 | $1,807,000 | +252.2% | 40,684 | +250.5% | 0.02% | +228.6% |
| Q4 2016 | $513,000 | -93.1% | 11,606 | -93.1% | 0.01% | -92.5% |
| Q2 2014 | $7,437,000 | +1171.3% | 168,447 | +1150.8% | 0.09% | +933.3% |
| Q1 2014 | $585,000 | -9.4% | 13,467 | -29.2% | 0.01% | -57.1% |
| Q3 2013 | $646,000 | -57.6% | 19,019 | -61.0% | 0.02% | -67.7% |
| Q2 2013 | $1,524,000 | – | 48,778 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 1,385,000 | $58,862,000 | 5.19% |
| SIGNIA CAPITAL MANAGEMENT LLC | 146,589 | $6,230,000 | 2.32% |
| HEARTLAND ADVISORS INC | 1,773,782 | $75,386,000 | 1.31% |
| NORTH TIDE CAPITAL, LLC | 350,000 | $14,875,000 | 1.30% |
| Aurora Investment Counsel | 38,196 | $1,623,000 | 1.07% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 571,150 | $24,274,000 | 0.99% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 102,500 | $4,356,000 | 0.90% |
| Tributary Capital Management, LLC | 98,862 | $4,202,000 | 0.83% |
| PERKINS CAPITAL MANAGEMENT INC | 27,850 | $1,184,000 | 0.80% |
| Iguana Healthcare Management, LLC | 25,000 | $1,063,000 | 0.61% |